297 related articles for article (PubMed ID: 16341343)
1. In vitro antimicrobial effect of cefazolin and cefotaxime combined with minocycline against Vibrio cholerae non-O1 non-O139.
Su BA; Tang HJ; Wang YY; Liu YC; Ko WC; Liu CY; Chuang YC;
J Microbiol Immunol Infect; 2005 Dec; 38(6):425-9. PubMed ID: 16341343
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of non-O1/non-O139 Vibrio cholerae isolates and polymerase chain reaction analysis of their virulence factors.
Lee YL; Hung PP; Tsai CA; Lin YH; Liu CE; Shi ZY
J Microbiol Immunol Infect; 2007 Dec; 40(6):474-80. PubMed ID: 18087626
[TBL] [Abstract][Full Text] [Related]
3. Changing characteristics of Vibrio cholerae: emergence of multidrug resistance and non-O1, non-O139 serogroups.
Chandrasekhar MR; Krishna BV; Patil AB
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1092-7. PubMed ID: 19062701
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of Vibrio cholerae non-O1 and non-O139 isolates associated with diarrhea].
González Fraga S; Villagra de Trejo A; Pichel M; Figueroa S; Merletti G; Caffer MI; de Castillo MC; Binsztein N
Rev Argent Microbiol; 2009; 41(1):11-9. PubMed ID: 19391519
[TBL] [Abstract][Full Text] [Related]
5. [Acute gastroenteritis caused by a Vibrio cholerae non-O1, non-O139 strain harboring a genetic region homologous to the VpaI-7 pathogenicity island].
Ulloa F MT; Porte L; Braun J S; Dabanch P J; Fica C A; Henríquez A T; Osorio A CG
Rev Chilena Infectol; 2011 Oct; 28(5):470-3. PubMed ID: 22051624
[TBL] [Abstract][Full Text] [Related]
6. Cefazolin plus minocycline against a clinical isolate of Vibrio vulnificus: in vitro and animal studies.
Tang HJ; Ko WC; Chuang YC; Chen CC; Chiang SR
Jpn J Infect Dis; 2010 Jan; 63(1):16-8. PubMed ID: 20093756
[TBL] [Abstract][Full Text] [Related]
7. [Non-O1, non-O139 Vibrio cholerae bacteremia in a chronic hemodialysis patient].
Zárate MS; Giannico M; Colombrero C; Smayevsky J
Rev Argent Microbiol; 2011; 43(2):81-3. PubMed ID: 21731967
[TBL] [Abstract][Full Text] [Related]
8. Non-O1, non-O139 Vibrio cholerae bacteremic skin and soft tissue infections.
Maraki S; Christidou A; Anastasaki M; Scoulica E
Infect Dis (Lond); 2016; 48(3):171-6. PubMed ID: 26503346
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection.
Chiang SR; Tang HJ; Chang PC; Cheng KC; Ko WC; Chen CH; Chuang YC
J Microbiol Immunol Infect; 2007 Apr; 40(2):123-33. PubMed ID: 17446960
[TBL] [Abstract][Full Text] [Related]
10. Vibrio cholerae non-O1, non-O139 strains isolated before 1992 from Varanasi, India are multiple drug resistant, contain intSXT, dfr18 and aadA5 genes.
Mohapatra H; Mohapatra SS; Mantri CK; Colwell RR; Singh DV
Environ Microbiol; 2008 Apr; 10(4):866-73. PubMed ID: 18201198
[TBL] [Abstract][Full Text] [Related]
11. Quinolone susceptibility of Vibrio cholerae O1 & O139 isolates from Vellore.
Jesudason MV; Balaji V; Thomson CJ
Indian J Med Res; 2002 Sep; 116():96-8. PubMed ID: 12619447
[TBL] [Abstract][Full Text] [Related]
12. Multiple antibiotic resistance profiles of Vibrio cholerae non-O1 and non-O139.
Kumar PA; Patterson J; Karpagam P
Jpn J Infect Dis; 2009 May; 62(3):230-2. PubMed ID: 19468189
[TBL] [Abstract][Full Text] [Related]
13. Invasive Vibrio cholerae non-O1 non-0139 infection in a thalassemic child.
Punpanich W; Sirikutt P; Waranawat N
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S226-30. PubMed ID: 22043781
[TBL] [Abstract][Full Text] [Related]
14. Diversity of Vibrio cholerae strains isolated in Delhi, India, during 1992-2000.
Das S; Gupta S
J Health Popul Nutr; 2005 Mar; 23(1):44-51. PubMed ID: 15884751
[TBL] [Abstract][Full Text] [Related]
15. GENOTYPE AND DRUG RESISTANCE OF CLINICAL AND ENVIRONMENTAL VIBRIO CHOLERAE NON-O1/NON-O139 IN NORTHEASTERN THAILAND.
Chomvarin C; Jumroenjit W; Tangkanakul W; Hasan NA; Chaicumpar K; Faksri K; Huq A
Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1354-64. PubMed ID: 26466421
[TBL] [Abstract][Full Text] [Related]
16. Multiresistant Vibrio cholerae non-O1/non-O139 from waters in South India: resistance patterns and virulence-associated gene profiles.
Jagadeeshan S; Kumar P; Abraham WP; Thomas S
J Basic Microbiol; 2009 Dec; 49(6):538-44. PubMed ID: 19810041
[TBL] [Abstract][Full Text] [Related]
17. A case of non-O1 and non-O139 Vibrio cholerae septicemia with endophthalmitis in a cirrhotic patient.
Yang CC; Lee BJ; Yang SS; Lin YH; Lee YL
Jpn J Infect Dis; 2008 Nov; 61(6):475-6. PubMed ID: 19050358
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Tang HJ; Chang MC; Ko WC; Huang KY; Lee CL; Chuang YC
Antimicrob Agents Chemother; 2002 Nov; 46(11):3580-4. PubMed ID: 12384368
[TBL] [Abstract][Full Text] [Related]
19. Non-O1, non-O139 Vibrio cholerae bacteraemia in an Australian population.
Trubiano JA; Lee JY; Valcanis M; Gregory J; Sutton BA; Holmes NE
Intern Med J; 2014 May; 44(5):508-11. PubMed ID: 24816311
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificus.
Tang HJ; Chen CC; Lai CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2018 Feb; 51(1):76-81. PubMed ID: 27260781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
